View More

THINK Surgical and CUREXO Announce Entry Into Development and Distribution Agreement

THINK Surgical, Inc., an innovator in the field of orthopedic surgical robots, today announced its entry into a development and distribution agreement with Curexo, Inc., a medical robotics specialist company based in South Korea. THINK and Curexo have a strong working relationship based on historical development collaboration and Curexo distributes THINK's TSolution One™ platform in Korea and Vietnam.Under the development and distribution agreement, THINK and Curexo will work together to include certain existing THINK technology and certain newly developed technology in Curexo's CUVIS-Joint orthopedic surgical robot platform. THINK will have exclusive rights to distribute the CUVIS-Joint robotic platform, including the additional technology, in the United States and other countries, including the United Kingdom and certain countries in the European Union.  The CUVIS-Joint robotic platform is currently being used by surgeons in Korea and India with great success. To date over 4,000 procedures have been performed. Curexo will continue to commercialize the CUVIS-Joint robotic platform, including new technology developed with THINK, outside of the countries in THINK's distribution territory. Curexo will also continue to distribute THINK's TSolution One™ platform in Korea and Vietnam.The CUVIS-Joint robotic platform is not yet cleared for sale in the United States. THINK will be responsible for seeking 510(k) clearance from the Food and Drug Administration (FDA) in the United States with support from Curexo to allow such sales. The companies will work together to seek regulatory clearance in other countries for the CUVIS-Joint robotic platform including additional technology."We are excited to deepen our relationship with Curexo and look forward to bringing the CUVIS-Joint platform to the United States and other markets," said Stuart Simpson, president and chief executive officer of THINK Surgical. "CUVIS-Joint is the next generation of active robot for joint replacement featuring an open implant library. As an open system that works with implants from multiple manufacturers, CUVIS-Joint is an outstanding fit within THINK's portfolio of products and services. THINK's open systems, including the CUVIS-Joint, offer a compelling alternative to closed systems which are limited to one manufacture's implants.""We are more than pleased to enter into this agreement with THINK, a long-standing financial and business collaborator of Curexo," said JJ Lee, chief executive officer of Curexo. "THINK is well positioned to successfully launch the CUVIS-Joint platform in these key markets, and Curexo has great confidence in the new leadership of THINK, led by CEO Stuart Simpson, given Stuart's deep experience in the orthopedic surgical robot business. We look forward to cooperating with THINK to obtain FDA clearance, develop new technology, and deliver new experiences with this next generation of active robot, thereby proving the value of the CUVIS-Joint platform to hospitals and surgeons in these important markets."About THINK Surgical®, Inc.THINK Surgical, Inc., a privately held U.S.-based medical device and technology company, develops, manufactures, and markets active robotics for orthopedic surgery. The TSolution One® Total Knee Application includes the only commercially available, active robot for total knee arthroplasty (TKA) utilizing an open implant library, supporting a variety of implant options.  The core technology of the TSolution One has been used in thousands of successful total joint replacements worldwide.THINK Surgical actively collaborates with healthcare professionals around the globe to refine our orthopedic products, improving the lives of those suffering from advanced joint disease with precise, accurate, and intelligent technology.  Please refer to the instructions for use for the TSolution One Total Knee Application for a complete list of indications, contraindications, warnings, and precautions. For additional product information, please visit www.thinksurgical.com.THINK Surgical and TSolution One are registered trademarks of THINK Surgical, Inc. ?2022 THINK Surgical, Inc. All rights reserved.About Curexo, Inc.Curexo Inc. is dedicated to developing cutting edge medical robots with the aim to provide value in life beyond treatment for a healthier tomorrow. Curexo manufactures two surgical robots, CUVIS-joint and CUVIS-spine, along with one rehabilitation robot, Morning Walk S200. Listed in the Korean Stock market, Curexo plans to increase its scale by growing internationally and working with global partners.Source : https://www.prnewswire.com/news-releases/think-surgical-and-curexo-announce-entry-into-development-and-distribution-agreement-301597044.html

View More

The steady supply of CUREXO, a medical robot. Supply volume increased significantly in the first quarter compared to the previous year.

Completed supply of 12 units in 1Q... The export of seven out of the 12 indicates a considerable achievement!Morning Walk covered by Health Insurance, new government policy boosts the rehabilitation robot market.Curexo's quarterly robot sales (the number of units supplied is based on sales recognition).Curexo announced that it had supplied a total of 12 medical robots in the first quarter of 2022.The number of units supplied in the first quarter of this year increased particularly compared to the first quarter of 2020 and the first quarter of 2021. Furthermore, seven out of twelve units are of great significance for overseas export.According to Curexo, eight units of 'Cubis-Joint,' an artificial joint surgery robot, were supplied to domestic hospitals and seven units to India. And the gait rehabilitation robot 'Morning Walk S200' and the upper extremity rehabilitation robot 'In Motion' has been supplied with three units and one unit, respectively, to domestic rehabilitation hospitals.A Curexo official declared, "The main factors for expanding the supply of medical robots in the first quarter of this year are the additional orders for 'Cubis-Joint' from India, the application of health insurance for domestic rehabilitation robots, and the expectation of market expansion for the new government's rehabilitation robot policies." "Thanks to these factors, the number of cases of artificial joint surgery with the Cubism Joint continues to increase in domestic and Indian hospitals, and clinical surgery with the demo robot has also produced satisfactory results, leading to additional supply contracts," he added.Curexo CS team employees are installing the gait rehabilitation robot 'Morning Walk S200' at a rehabilitation hospital.Curexo CS team employees are installing the gait rehabilitation robot 'Morning Walk S200' at a rehabilitation hospital.Curexo CEO Jaejoon Lee said, "The medical robot business performance varies from quarter to quarter, but annual supply expansion and sales growth are noteworthy." "Despite the aggravated global supply chain and the coronavirus, we expect to record positive sales results in the first quarter because we are confident of securing inventory, shortening the production period, and delivering quickly," he counted. "In addition, we are promoting the excellence of Curexo medical robots by conducting continuous marketing through participation in medical device conferences held at home and abroad," he expressed.Meanwhile, Curexo's self-developed gait rehabilitation robot 'Morning Walk S200' started to be covered by health insurance from February 1 in accordance with a partial revision of the Ministry of Health and Welfare's 「Standards for Selection and Implementation of Selective Benefits」.A Curexo representative stated, "We are already close to our domestic sales target of 6 units. We had set for selling three units of the Morning Walk S200 in the first quarter and one unit in the second quarter." "We plan to raise our domestic sales target as we expect the sales increase with health insurance benefits, identified as the biggest obstacle, are resolved," he declared.source : http://www.k-health.com/news/articleView.html?idxno=58890

View More

New Strategic Partnership between CUREXO Inc. and Fourier Intelligence

Medical robot specialist CUREXO Inc. and rehabilitation robotics vanguard Fourier Intelligence announces their strategic global partnershipFrom top left : Mr Zen Koh, and Mr Jae Jun Lee. From bottom left: Mr Owen Teoh, Mr Jean Cho, and Ms Sandra Lee.Medical robot specialist CUREXO Inc. and rehabilitation robotics vanguard Fourier Intelligence announces their strategic global partnershipWe are excited for this strategic partnership with CUREXO to further enrich our global market offerings. Together, we will further our mission to providing intelligent rehabilitation technologies."Mr Zen Koh, CEO of Fourier Intelligence’s Global HubSINGAPORE, August 20, 2021 /EINPresswire.com/ -- Fourier Intelligence has announced a partnership with CUREXO Inc., the company behind the world’s first "fully automated surgical robot". This partnership will initially focus on the distribution of CUREXO’s Morning Walk to the global network.The Morning Walk from CUREXO is a gait rehabilitation robotics suited for pediatrics and adult populations. With the recent CE certification, it allows the novel end-effector gait rehabilitation robot to be offered into countries outside of Korea. This partnership leverages Fourier Intelligence’s vast network of global sales partners with its presence in over 50 countries such as Singapore, Malaysia, Thailand, the United Kingdom, Australia, and many more."We are excited for this strategic partnership with CUREXO to further enrich our global market offerings," said Zen Koh, Co-Founder and CEO of Fourier Intelligence’s Global Hub. "Together with Jae Jun and his team, we will also work towards future joint technological development, furthering our mission to providing intelligent rehabilitation technologies to empower clinicians and their patients."CUREXO’s CEO, Mr. Jae Jun Lee states that "I am thrilled for this partnership with Fourier Intelligence, which will be a great asset in getting awareness in the global market. The end-effector gait rehabilitation robot Morning Walk has 18 installation sites in Korea. Now is the time to move out to compete with the international ps, and this alliance with Fourier Intelligence’s Global Hub has given us the strength to start the journey."CUREXO is one of the many companies working together with rehabilitation robotics pioneer Fourier Intelligence in providing robotics for rehabilitation. The vanguard company works with various other well-known manufacturers to positively disrupt the industry and serves true to its mission as a ‘One-Stop Solution Provider of Robotics for All’. It recently completed an extended C+ round funding led by Prosperity7 Ventures, an Aramco Venture Fund, to further its global market expansion plan.The Morning Walk will now be part of Fourier Intelligence’s RehabHub™. The comprehensive rehabilitation concept is equipped with highly efficient, compact, modular, interconnected, and cost-effective robots that deliver efficacious functional training. Building upon group therapy models, the RehabHub™ serves well in rehabilitation to assist clinicians in providing highly intensive, challenging, and effective treatments. This constructively frees up the clinician from monotonous and tedious physical interventions to offer a personalized treatment program to patients.This partnership also brings together collective talents in technology development, deployment, product strategy roadmap, and innovation to support clients through lucrative healthcare transformations.About Fourier IntelligenceFourier Intelligence is a technology-driven company, infusing creativity into exoskeleton and rehabilitation robotics development since 2015. The company's name derives from 'Fourier Transform', which is named in honor of Jean-Baptiste Joseph Fourier (Mar 21, 1768 ? May 16, 1830), a French mathematician. Fourier Transform is a mathematical operation that changes the domain (x-axis) of a signal from time to frequency. Together with researchers, engineers, therapists, patients, and various strategic stakeholders, Fourier Intelligence aims to transform the industry by introducing an intuitive RehabHub™ and redefining rehabilitation and robotics solutions to enhance patients' lives.Find out more at www.fftai.comAbout CUREXO Inc.CUREXO Inc. is a dedicated medical health care robot development-orientated company that aims to provide value in life, not just treatment but beyond, to make a healthier tomorrow. CUREXO has a lineup of two surgical robots CUVIS-joint and CUVIS-spine, along with one rehabilitation robot, Morning Walk. Listed in the Korean Stock market, CUREXO plans to increase its scale by moving out internationally and working with global partners.Find out more at www.curexo.com/english/https://www.einnews.com/pr_news/549229897/new-strategic-partnership-between-curexo-inc-and-fourier-intelligence

View More

'Morning Walk S200', CUREXO's walking rehabilitation robot, has acquired European CE certification

SEOUL, South Korea, May 18, 2021 /PRNewswire/ -- On the 17th, the medical robot specialist company CUREXO (060280) announced that their next-gen walking rehabilitation robot, the 'Morning Walk S200', acquired CE certification. This is the 3rd certificate that the 'Morning Walk S200' has acquired, followed by MFDS (Korea) and FDA (US) certificates this February.The 'Morning Walk' of CUREXO is a walking rehabilitation robot for everyone from children to adults. Currently, it is being used by 16 rehabilitation hospitals in Korea to assist with patient rehabilitation.By acquiring the European CE certificate, the company can now advance to 28 EU countries, 3 EFTA countries, EU candidate countries and neutral countries. Also, after acquiring the MDFS (Korea), the company has recently won 2 national project contracts and has also been supplying its solution to the rehabilitation hospitals in the Gyeongbuk region.Many research papers prove the stability and usefulness of the 'Morning Walk' for cerebral stroke, spinal cord injuries, Parkinson's disease, peripheral nerve disease, and artificial knee joint patients.According to the article, 'Effects of robot-(Morning Walk ®) assisted gait training for patients after stroke: a randomized controlled trial' in the SCI Journal 'Clinical Rehabilitation, 2019, Vol.33' In a randomized control trial with 58 cerebral stroke patients to assess the rehabilitation performance of 'Morning Walk,' the 'Motricity Index' that indicates the strength of lower extremity and the 'Berg Balance Scale' that evaluates the patients' balancing ability have shown statistically significant improvements compared to the control group. 'Montricity Index' has improved approximately 69.8% and 'Berg Balance Scale' has improved approximately 49.0% compared to the control groups.According to the article 'Five-day rehabilitation of patients undergoing total knee arthroplasty using an end-effector gait robot as a neuromodulation blending tool for deafferentation, weight offloading and stereotyped movement: Interim analysis' published in the medical journal 'PLOS ONE, 2020 Vol.15', During 5 days of randomized control trials, the 'Morning Walk' and other medical walkers were used by artificial joint surgery patients. Based on the electrophysiological evaluation and biomechanical measuring technique, the patients who used 'Morning Walk' showed 2.65 times higher strength growth rate than the control group.According to the article, 'Feasibility of Robot-Assisted Gait Training with an End-Effector Type Device for Various Neurologic Disorders,' published in neurorehabilitation journal 'Brain & NeuroRehabilitation, 2020 Vol.13,' the control experiment with 100 brain injury patients, 40 spinal cord injury patients, 8 Parkinson's disease patients, 9 peripheral nerve disease patients, 22 pediatric patients (total 189) showed a significant improvement in both Medical Research Council (MRC) that evaluates the strength and Functional Ambulatory Category (FAC) that indicate walking ability.CEO Jae-Joon Lee stated "I am glad that the 'Morning Walk S200' has acquired European CE certification allowing us to expand our market to the European medical rehabilitation market, followed by Korea and the US." He also said that "Many research papers have confirmed that the rehabilitation utilizing 'Morning Walk' significantly improves stability and effectiveness compared to the control group. This demonstrates that the 'Morning Walk' has a wide range of applications. For the past years, we have listened to the feedback of our patients and medical staff who used 'Morning Walk' and continuously improved our solution. As a result, the 'Morning Walk' is now being supplied to 16 rehabilitation hospitals in Korea and is going to be sold overseas. As we have obtained the permits in the US and Europe, we plan to expand our business in the advanced medical market.Media ContactHoyong Lee, hylee@curexo.comSOURCE CUREXO

View More

CUREXO dashes into overseas markets with last year’s results, achieving best quarterly performance ever

Curexo, a medical robot company, said it recorded its highest quarterly performance thanks to increased sales of medical robots in the fourth quarter of 2020.According to the company, sales in the fourth quarter were 12.7 billion KRW (YoY +39%, QoQ +41.7%), operating profit was 14.8 billion (YoY surplus conversion, QoQ +250.1%), and net profit was 1.66 billion (YoY surplus conversion, QoQ +165%) respectively. The annual sales grew 14.2 percent year-on-year to 392.8 billion, operating profit reached 7.3 billion, and net profit reached 640 billion KRW, respectively.Curexo succeeded in expanding sales and making a surplus by supplying its medical robots to various internal and external medical sites last year.Specifically, last year's results included a total of 18 units, including eight artificial joint surgery robots, "CUVIS-joint," three spinal surgical robots, "CUVIS-spine," and five walking rehabilitation robots, "Morning Walk," to the domestic and overseas medical markets. As a result, Curexo has established itself as a leading medical robot company in Korea and has secured both growth and profitability.The company's CEO, Lee Jae-jun, said, "As a representative of the company, I am grateful that we were able to supply medical robots to the domestic and overseas medical markets with the dedication and efforts of executives and employees even amidst COVID-19.""In the second quarter of this year, we are aiming to obtain domestic and overseas licenses," he added. "We will not stop at last year’s success but do our best to advance into developed markets such as the U.S. and Europe, the cores of global medical robot markets, establishing the status of K-medical robots in the global medical robot market by signing strategic partnerships, promoting joint projects, and building brand awareness and expanding supplies."https://www.k-health.com/news/articleView.html?idxno=52292

View More

"CUVIS-spine," CUREXO's spinal surgical robot... success of its first surgery at the Severance Hospital

"CUVIS-spine," spinal surgical robot developed by CUREXO, the medical robot specialized company, successfully performed its first operation at the Severance Hospital, Sinchon.According to the company, "CUVIS-spine" had successfully carried out the insertion of pedicle screws on a patient with spinal stenosis and degenerative spondylolisthesis. After the surgery, image examinations had proven the fixation of the screws as originally planned, and the patient was able to leave the hospital on the fifth day with improvements.Dr. Seong Yi?of the department of neurosurgery at the Severance Hospital, Sinchon?is inserting the screws using CUVIS-spine.Until now, to increase the surgical accuracy, movable X-ray equipment, C-arm, was used and observed in real-time, which raised the risk of exposure to radiation for both the patients and medical team. But surgery with robots enables accurate and safe operation without such risk.CUVIS-spine, especially, is the first spinal surgical robot to be domestically developed in the country and fifth to be commercialized in global medical fields.CUVIS-spine is equipped with the system of a spinal surgical robot that guides the location and position of surgical instruments, and surgical accuracy increases as it plans a surgery based on 2D C-arm or 3D CT images and corrects while monitoring the patient's posture in real-time during the insertion of pedicle screws into patients with spinal stenosis, spinal disc herniation, or scoliosis. Also, safety increases as the exposure to radiation are lessened during the surgery. Thanks to this, patients can quickly return to their daily lives."I expect that Korean robots will be able to enter the market by accumulating track records and creating clinical evidence in the field of spinal surgical robots, which is expanding globally," Dr. Seong Yi, of the department of neurosurgery at Severance Hospital, who participated in developing CUVIS-spine, said. "Linked with the Medical Robot Training Center?which will be established at the Severance Hospital over the next five years?the clinical data of spinal surgical robots, including safety, validity, and radiation safety level will contribute to the development and globalization of the domestic surgical robot industry."Severance Hospital said it would apply CUVIS-spine to a total of 50 spinal surgeries this year, followed by the introduction of the robot."This successful spinal robotic surgery at the Severance Hospital is a great chance to prove the excellence of our medical robot," CEO Jae-jun Lee of CUREXO commented. "In the future, we will develop more advanced medical robots and actively proceed with the entry of domestic and overseas medical sites through our continued cooperation with the Severance Hospital."Meanwhile, CUVIS-spine had acquired CE markings from the Ministry of Food and Drug Safety last December and from Europe last May. It completed submitting s to the U.S. FDA and is now waiting for approval.http://www.k-health.com/news/articleView.html?idxno=51098

View More

Sakra Hospital launches world's first fully active robotic knee replacement system

HighlightsSakra World Hospital launched advanced robotic knee replacement technology that is set to empower the orthopaedic surgeons to plan the knee replacement days before they enter the operation theatre to actually conduct the procedure. Bengaluru: Sakra World Hospital launched advanced robotic knee replacement technology that is set to empower the orthopaedic surgeons to plan the knee replacement days before they enter the operation theatre to actually conduct the procedure.Meet CUVIS Joint, the world's first fully active robotic knee replacement system which is now making knee replacement surgeries more accurate, transparent and hassle-free in Sakra World Hospital and comes as a bliss for those suffering from severe arthritis. Manufactured by Curexo, a South Korean firm and marketed and sold by Meril Healthcare in India and known for its unique and autonomous nature of functioning, CUVIS Joint was launched by BS Yediyurappa, Hon'ble Chief Minister of Karnataka and Dr Shivaraj Kumar, popular Kannada film actor.https://www.thehansindia.com/bengaluru/sakra-hospital-launches-worlds-first-fully-active-robotic-knee-replacement-system-661876?infinitescroll=1

View More

Activation of CUREXO "CUVIS-joint," an artificial joint surgical robot, at Korean medical sites

First supply to Chung-Ang University Hospital in Korea following advancement abroad such as India"CUVIS-joint," an artificial joint surgical robot, from CUREXO (060280), a medical robot company, will take its first step into a medical site in Korea.CUREXO has stated that Chung-Ang University Hospital will be the first in Korea to be supplied with CUVIS-joints through a demonstration project organized by the Korea Institute for Robot Industry Advancement.After obtaining a manufacturing license in Korea for CUVIS-joint from the Korean Ministry of Food and Drug Safety, CUREXO signed a large-scale, long-term supply contract with the Indian implant company "Meril Healthcare" in June. Since then, CUVIS-joints have been used in carrying out demonstration tests together with several domestic medical institutions. Out of them, Chung-Ang University Hospital became the first to be supplied with the robot.According to CUREXO, the artificial joint surgical robot "CUVIS-joint" is a completely automatic surgical robot system that cuts bones for artificial joints to be inserted more accurately. Based on CT images, patient-based preoperative plans can be established, allowing cutting bones more accurately and safely. Its feature is the ease of use, reducing fatigue for surgeons.The artificial joint surgical robot, CUVIS-joint, exclusively developed by CUREXO, is now performing in Korean medical institutions beginning with the first supply at Chung-Ang University Hospital.In particular, bones cannot regenerate once cut off, so preserving bones as much as possible by minimizing the cutting area is vital. CUVIS-joints can preserve healthy bones as much as possible through accurate diagnosis, patient-based preoperative plans, and precise cutting.There are many benefits to patients as well. Correcting the alignment of the leg axis with accurate surgery lessens pain and provides a shorter recovery period than traditional surgery, which can significantly reduce the possibility of side effects and reoperation."We will do our best to inform the excellence of CUVIS-joints and supply them to various hospitals in Korea, starting with Chung-Ang University Hospital. Also, we expect sales and profitability to improve from the third quarter of the year, through the promotion of additional overseas launching including India, following the successful contract on major medical robots from July," CEO Jae-jun Lee from CUREXO commented.Source : http://www.k-health.com/news/articleView.html?idxno=50030

View More

Experience CUREXO Medical Robots at More Hospitals

Consecutively providing "CUVIS-spine" and "Morning Walk" to domestic, highest performing general hospitalsCUREXO's medical robots are expected to vitalize robot rehabilitation treatment sites.CUREXO(060280), a medical robot specialized company, has revealed that it will supply a spinal surgery robot "CUVIS-spine" to Severance Hospital, walking rehabilitation robot "Morning Walk" to Jeonbuk National University Hospital and Saerom Rehabilitation & Nursing Hospital each, as part of the "medical rehabilitation robot supply project" jointly promoted by the Ministry of Trade, Industry and Energy, the Korea Institute for Robot Industry Advancement, and the National Rehabilitation Center.The "medical rehabilitation robot supply project" aims to prove the efficiency of robot rehabilitation and distribute them to various medical sites by discovering robots with high market potential and demonstrate testing them at domestic medical institutions.CUREXO's robot for spinal surgery "CUVIS-spine (left)" and for walking rehabilitation "Morning Walk (right)"According to CUREXO, CUVIS-spine is a robot for spinal surgery which has been supplied with a contract for research and development between Severance Hospital and CUREXO. Currently, Severance Hospital is operating the most robotic surgeries among the highest performing general hospitals in the country.CUVIS-spine has acquired licensing from the Korean Ministry of Food and Drug Safety in December 2019 and the CE certification from Europe this May, and it is now looking forward to U.S FDA's licensing after completing all procedures for the approval.A robot for walking rehabilitation Morning Walk has been installed in major rehabilitation hospitals across the country, starting from the National Rehabilitation Center in 2015 and to hospitals, including Jeonbuk National University Hospital and Saerom Rehabilitation & Nursing Hospital. Now, a total of 14 Morning Walks are in use for treating patients with lower extremity disabilities. Moreover, the upgraded version of Morning Walk, "Morning Walk S200," is completed developing and will prepare for licensing in the country within the second half of this year."As we supply to Korea's advanced general hospitals some various medical robots such as "CUVIS-spine" and "Morning Walk," which we've developed with our own technologies over a long period, I believe we are taking a first step toward becoming medical robot specialized company," Jaejun Lee, the CEO of CUREXO said. "I am expecting an increase in sales along with profitability improvements, as 'CUVIS-Joint,' in addition to domestic supply, successfully signed a long-term contract with 'Meril Healthcare,' the largest implant firm in India," he added.Meanwhile, CUREXO is actively marketing its various medical robots to Korean hospitals and overseas distributors and is determined to focus on achieving additional sales in the next half of the year, excluding already fixed domestic and overseas contracts.Source: http://www.k-health.com/news/articleView.html?idxno=49552